Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa. Num. Pages Manejo clínico de las hiperprolactinemias. Clinical management of hyperprolactinemia. Visits. Download PDF. La frecuencia de hiperprolactinemia en esta entidad es del 13 al 59% y los . Artículo. B. Farzati,G. Mazziotti,G. Cuomo,M. Ressa,F. Sorvillo,G. Amato.

Author: Shajind Sanris
Country: Uruguay
Language: English (Spanish)
Genre: Education
Published (Last): 20 September 2014
Pages: 205
PDF File Size: 16.92 Mb
ePub File Size: 17.92 Mb
ISBN: 199-2-39709-917-3
Downloads: 50342
Price: Free* [*Free Regsitration Required]
Uploader: Faele

Clin Endocrinol Oxf71pp. From Monday to Friday from 9 a. National Center for Biotechnology InformationArtticulo. The cardiovascular risk associated with PHPT is attributable in large part to an increased prevalence of hypertension, obesity, glucose intolerance, and insulin resistance.

Rheum Dis Clin North Am, 27pp. Berek and Novak’s Gynecology. Clin Rheumatol, 25pp. An exception could be microadenomas with no decrease in tumor size but with radiographic changes suggesting necrosis, provided PRL levels are kept controlled with low doses of dopamine agonists.


Manejo clínico de las hiperprolactinemias | Revista Clínica Española (English Edition)

Macroadenoma refractory to treatment with dopamine agonists. Thyroid hormone also promotes an increase in blood volume via up-regulation of erythropoietin secretion, further enhancing cardiac preload.

CiteScore measures average citations received per document published. Conclusions The document provides evidence-based practical and biperprolactinemia recommendations for diagnosis and management of hyperprolactinemia and prolactinoma, including drug-induced hyperprolactinemia, treatment options for prolactinoma drugs, surgery, and radiotherapyprolactinoma in pregnancy, adverse effects of dopaminergic agents, and drug-resistant and malignant prolactinomas.

Related Posts  D20 MECHA CRUSADE PDF


SNIP measures contextual citation impact by wighting citations based on the total number of citations in hioerprolactinemia subject field. Excess ACTH can be produced by pituitary corticotroph adenoma or, rarely, by an extrapituitary tumor ectopic ACTH syndrome such as hiperprolactinemi cell lung cancer, carcinoid tumor, or medullary thyroid cancer.

The impact on clinical practice of routine screening for macroprolactin. However, hormone replacement therapy HRT to replenish estrogen deficit should be given to all patients with amenorrhea. A diagnosis of malignancy is only made based on tumor extension to non-contiguous areas of the central nervous system or with the presence of metastasis.

Once physiological causes such as pregnancy, systemic disorders such as primary hypothyroidism and the use of drugs with dopamine antagonistic actions such as metochlopramide have been ruled out, the most common cause of hyperprolactinemia hipperprolactinemia a PRL-secreting pituitary adenoma or prolactinoma. Ergot derivativeD2 agonistD1 agonist.

High prolactin and low dehidro-epiandrosterone sulphate serum levels in patients with severe systemic sclerosis.


Cases where menopause may be related to the resolution of hyperprolactinemia have also been reported. Tumor may be multifocal in origin. Apolipoprotein B and the atherogenic LDL variant, lipoprotein aare also increased in hypothyroidism. The electrocardiographic signs related to pheochromocytoma include right-axis deviation, poor R-wave progression, inverted T waves, and QT prolongation.

Epidemiology and natural history of systemic sclerosis. Pattern of increase in circulating prolactin levels during human gestation. This item has received. From Monday to Friday from 9 a. A response to bromocriptine has been achieved in some patients refractory to cabergoline. Hypogonadism induced by hyperprolactinemia is associated with decreased mineral bone density in both sexes.


J Clin Endocrinol Metab, 90pp. March Next article.

Continuing navigation will be considered as acceptance of this use. No evidence is yet available on the superiority of new endoscopic procedures over prior techniques in transsphenoidal surgery. Cardiac valve disease aortic and mitral regurgitation is frequent in acromegaly. Mean dose is 0. Images subject to Copyright.